Loading...

Stay current with insights from our analysts and industry updates.  Subscribe to one of our HealthCheck24 newsletters to receive regular weekly insights by email. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.

Chinese pharma growth slowed again in 2014 but still impressive

Image

25-Jan-15The Chinese pharmaceutical sector saw lower growth in 2014 due to a host of challenges including slowing overall economic growth, regulatory shakeups, cost containment measures and price cuts, as well as healthcare reform turbulence. However, the market is still estimated to have grown 13% in 2014, to reach USD200 billion. [image: My Jungle Blog]

For more about China's healthcare sector, request our free 20-page whitepaper: China Healthcare Market Opportunities

Read More
Share